Navigation Links
Hoya Announces Fourth Quarter and FY2007 Financial Results
Date:4/28/2008

usiness units are consolidated. Life Care net sales increased year-on-year basis driven by strong sales of new endoscopic system. Imaging System net sales decreased year-on-year basis due to the sales decline of compact type digital camera. Optical Component net sales increased year-on-year basis resulting from steady performance of value-added digital camera module.

Business Highlights for the Full Year

Electro-optics net sales were 209.8 billion yen, an 4.3% decrease over the prior year. Vision Care net sales were 126.3 billion yen, 5.5% up over the prior year. Health Care net sales were 46.1 billion yen, 13.0% up over the prior year. The net sales of 89.0 billion yen from newly consolidated Pentax businesses and its subsidiaries for the six months from October 1, 2007 to March 31, 2008 have been combined to the full year results.

HOYA also announced year-end dividends forecast of 35 yen per share of common stock. The annual dividend, including the interim dividends of 30 yen per share, will amount to 65 yen per share. It will be decided at the board of directors meeting in the end of May.

For the full quarterly report please access "Hoya Quarterly" in Investor Relations page of HOYA website at: http://www.hoya.co.jp/english/

*Results are preliminary and unaudited.

*The yen amounts shown therein are rounded down to the nearest 100 million.

About Hoya Corporation:

Hoya Corporation (TSE: 7741) is a global technology company based in Tokyo, Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: Electro-Optics makes mask blanks and photomasks for the fabrication of semiconductor devices and liquid crystal panels, optical lenses for use in digital cameras, and glass memory disks for hard disk drives. The Eye Care business provide
'/>"/>

SOURCE Hoya Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - Resverlogix ... of common shares of Resverlogix have approved the ... Eastern Capital Limited of 5,600,000 units at a ... Placement"), each unit being comprised of one common ... aggregate proceeds of approximately CAD$15 million; and (ii) ...
(Date:6/30/2015)... -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ), a specialty ... unmet medical needs in women,s health, today announced ... at the Cantor Fitzgerald Inaugural Healthcare Conference as ... PM EDTLocation: , Le Parker Meridien Hotel, New ... under  ,Investor, or  click here The ...
(Date:6/30/2015)... WA (PRWEB) , ... June 30, 2015 , ... ... a hydrophilic filter that does not sacrifice selectivity to achieve faster flow rates ... combines extremely fine pores with significant open space to allow easy liquid flow ...
Breaking Biology Technology:UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2
... , , , ... Board: SYMD), a biomaterials company engaged in the development ... the company,s bioresorbable adhesion barrier film for the reduction ... the Brazilian Ministry of Health for use in all ...
... DURHAM, N.C., Sept. 9 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: ... asks shareholders to approve a 1-for-15 reverse stock split at the ... "At last years, general annual meeting we explained the problems of ... promised to seek a listing change as soon as we can ...
... MUMBAI, India, September 9 , ... its First Domain-Specific Learning,and Consulting Solutions for Health Care ... Interactive Systems (TIS)-has,recently announced the launch of its first ... industry. TIS formally,launched this initiative with the appointment of ...
Cached Biology Technology:SyntheMed Receives Brazilian Regulatory Approval for REPEL-CV(TM) 2Oxygen Biotherapeutics, Inc. Seeks Shareholder Approval for Reverse Stock Split 2Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 2Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 3Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 4
(Date:6/25/2015)... PRINCETON, N.J. , June 25, 2015  TAKE ... awarded a patent by the United States Patent and ... Data Standardization". This process leverages TAKE Solutions, Clinical Accelerators ... by over 50% (when compared to standardization without the ... At the heart ...
(Date:6/24/2015)... 22, 2015 Research ... of the "Huawei Ascend Mate 7 Fingerprint ... their offering. Huawei,s technological choice for ... direction than Apple,s and Samsung,s one. The Ascend ... by Fingerprint Cards, a main actor in capacitive ...
(Date:6/23/2015)... June 23, 2015   Valencell, a ... results of a recent study that illustrates its ... wrist during activity. In a study conducted at ... along with the Apple Watch against a chest ... rate during activity. The study demonstrated that Valencell,s ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3
... amphibian species at an accelerating rate in recent decades, ... 2003. At the same time, amphibians are, for reasons ... or birds, underscoring the importance of an accurate evaluation. ... of BioScience, the monthly journal of the American Institute ...
... running, reports a team of scientists from The University of ... for the environment. Arizona farmers who plant the biotech cotton ... in the past. , Insect pests sometimes evolve resistance to ... was predicted for biotech crops genetically altered to produce Bt ...
... disease in medieval Europe ?to fade from the scene? ... there. , The reason seems to be, say researchers ... that tuberculosis, a far more deadly disease, overtook leprosy, ... upon the examination of DNA from human remains from ...
Cached Biology News:New amphibian species result from exploration, not from rule changes 2Biotech cotton 8: Bugs 0 2Biotech cotton 8: Bugs 0 3Once-dreaded leprosy 'replaced' by tuberculosis, say researchers 2
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
... Polymerase I from E. coli ... The enzyme also contains both ... 5'?3' exonuclease activity enables the ... gaps in the DNA as ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... Description: Topoisomerase I relaxes both positively and negatively ... of phosphodiester bonds (1,2) . Relaxing supercoiled DNA ... by a single nucleotide pair by gel electrophoresis ... absence of Mn 2+ and can be ...
Biology Products: